BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9098195)

  • 1. Soft-tissue uptake of technetium-99m-MDP after prostate cryoablation.
    Zucker I; Charkes ND; Seidmon EJ; Maurer AH
    J Nucl Med; 1997 Apr; 38(4):525-8. PubMed ID: 9098195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
    al-Nahhas AM; Jinnouchi S; Anagnostopoulos C; Hirsch W; Heary T; McCready VR
    Eur J Nucl Med; 1995 Feb; 22(2):148-53. PubMed ID: 7758502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraosseous Tc-99m MDP uptake: a pathophysiologic approach.
    Peller PJ; Ho VB; Kransdorf MJ
    Radiographics; 1993 Jul; 13(4):715-34. PubMed ID: 8356264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher scrotal uptake ratio of (99m)Tc-MDP on bone scans in newly diagnosed prostate cancer: a reliable indicator of pelvic node metastasis.
    Zaman MU; Fatima N; Sajjad Z; Hashmi I; Khan K
    Ann Nucl Med; 2012 Oct; 26(8):676-80. PubMed ID: 22777858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
    Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
    Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
    [No Abstract]   [Full Text] [Related]  

  • 6. Ivory vertebra appearing photopenic on Tc-99m MDP bone scan: demonstration by SPECT/CT.
    Aide N; Costo S; Lheureux S; Allouache N; Bardet S
    Clin Nucl Med; 2008 Jul; 33(7):479-81. PubMed ID: 18580234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracheal uptake on Tc-99m MDP bone scintigraphy can be a potential source of false-positive results in a prostate cancer patient.
    Sood A; Sethi S; Kumar R
    Clin Nucl Med; 2010 Jun; 35(6):454-5. PubMed ID: 20479601
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse abdominal uptake of technetium-99m-methylene diphosphonate in a patient on continuous ambulatory dialysis during bone scintigraphy.
    McDevitt GR; Heironimus JD; Toney MO; Billingsley JL
    J Nucl Med; 1992 Nov; 33(11):2052-4. PubMed ID: 1432173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of increased scrotal Tc-99m MDP uptake in patients with prostate cancer.
    Selcuk NA; Sayman HB; Kanmaz B; Turkmen C; Selcuk H; Nisli C; Uslu I
    Nucl Med Commun; 2011 Feb; 32(2):155-8. PubMed ID: 21085045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPECT-CT for characterization of extraosseous uptake of 99mTc-methylene diphosphonate on bone scintigraphy.
    Soundararajan R; Naswa N; Sharma P; Karunanithi S; Nazar AH; Das KJ; Bal C; Malhotra A; Kumar R
    Diagn Interv Radiol; 2013; 19(5):405-10. PubMed ID: 23748034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitargeted tyrosine kinase inhibition produces discordant changes between 99mTc-MDP bone scans and other disease biomarkers: analysis of a phase II study of sunitinib for metastatic castration-resistant prostate cancer.
    Saylor PJ; Mahmood U; Kunawudhi A; Smith MR; Palmer EL; Michaelson MD
    J Nucl Med; 2012 Nov; 53(11):1670-5. PubMed ID: 22984218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
    Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
    Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical usefulness of 123I-IMP scintigraphy in the diagnosis of bone metastases from hepatocellular carcinoma: comparison with 99mTc-MDP bone scintigraphy].
    Suto Y; Tanigawa N; Iwamiya T; Kato T; Endo K; Shabana M; Ohta Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):953-9. PubMed ID: 8396760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic hemangioma. Detection on a technetium-99M MDP bone scan.
    Katz DS; Wojtowycz AR; Markarian B
    Clin Imaging; 1994; 18(4):279-82. PubMed ID: 8000957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
    Higashiyama S; Yoshida A; Kawabe J
    Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate.
    Hoefnagel CA; Bruning PF; Cohen P; Marcuse HR; van der Schoot JB
    Diagn Imaging; 1981; 50(5):277-84. PubMed ID: 6457735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
    Haseman MK
    Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.